Lytus Technologies Holdings PTV. LTD. (LYT)

NASDAQ: LYT · IEX Real-Time Price · USD
+0.62 (12.11%)
At close: Jul 5, 2022 4:00 PM
-0.15 (-2.61%)
After-hours: Jul 5, 2022 5:33 PM EDT

Company Description

Lytus Technologies Holdings is a growing platform services company primarily providing content streaming/telecasting services with over 8 million active users located all across India.

Our scope of business also covers telemedicine services with local assistance through local Health Centers. Through our platform, our customers are well connected via customer premises equipment (“CPE”) devices/set top boxes (“STBs) and have access to multi-dimensional services.

We have been focused on adopting and implementing technologies that can change the landscape of being a conventional streaming services provider. We intend to benefit from India’s e-commerce boom and the recent tele-medicine regulation through the acquisition of Global Health Sciences, Inc. (“GHSI”).

Our healthcare work will focus on providing telemedicine solutions for the unmet medical needs of a large part of the Indian population. Our unique addition to conventional telemedicine is in the form of local health centers staffed by trained nurses, both male and female, to assist the doctor to thoroughly examine the patient and administer treatment such injections as per the advice of the doctor on the video consultation.

Lytus Technologies Holdings PTV. LTD.
Country India
Founded 2020
IPO Date Jun 15, 2022
Industry Software-Application
Sector Technology
Employees 38
CEO Dharmesh Pandya

Contact Details

601 Everest Grande, A Wing, Mahakali Caves Road
Andheri (East), Mumbai 400 093
Phone 91 28 4494 2810

Stock Details

Ticker Symbol LYT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
IPO Price $4.75
CIK Code 1816319
SIC Code 7374

Key Executives

Name Position
Dharmesh Pandya Chief Executive Officer and Director
Shreyas Shah Chief Financial Officer ? Global and Director
Jagjit Singh Kohli India Chief Executive Officer - IPTV and Director
Rajeev Kheror Global C.E.O - OTT and Studios
James Tuchi USA Chief Executive Officer of Telemedicine

Latest SEC Filings

Date Type Title
Jun 23, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 16, 2022 424B4 Prospectus [Rule 424(b)(4)]
Jun 15, 2022 EFFECT Notice of Effectiveness
Jun 14, 2022 CERT Certification by an exchange approving securities for listing
Jun 13, 2022 8-A12B Registration of securities [Section 12(b)]
Jun 8, 2022 POS AM Post-Effective amendments for registration statement
Jun 1, 2022 POS AM Post-Effective amendments for registration statement
May 4, 2022 POS AM Post-Effective amendments for registration statement
Apr 6, 2022 FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 1, 2022 EFFECT Notice of Effectiveness